Amphista is a biotechnology company focused on developing and commercializing innovative therapeutic solutions for diseases associated with protein misfolding and aggregation. The company utilizes its proprietary platform to discover and optimize small molecule drugs aimed at modulating protein interactions and promoting cellular health.